Skip to main content
All lobbying filings

BROAD INSTITUTE INC.

Lobbying for BROAD INSTITUTE INC. · Biomedical and Genomic Research

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $70,000.00 expenses · posted May 27, 2026

Official filing document

 Lobbying activity 4
Budget/Appropriations

- General education about biomedical research and support for scientific funding. Transparency of federal funding for medical research dollars, including indirect costs. Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments. - Federal funding for research and policy issues related to biomarkers and stress biology, including potential applications in defense and human performance. Fiscal Year 2027 National Defense Authorization Act (NDAA) and Fiscal Year 2027 Defense Appropriations. Federal policies and investments related to data infrastructure and artificial intelligence for biomedical research, including standards for secure and scalable data ecosystems.

Science/Technology

- General education about biomedical research and support for scientific funding. Transparency of federal funding for medical research dollars, including indirect costs. Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments. - Federal funding for research and policy issues related to biomarkers and stress biology, including potential applications in defense and human performance. Fiscal Year 2027 National Defense Authorization Act (NDAA) and Fiscal Year 2027 Defense Appropriations. Federal policies and investments related to data infrastructure and artificial intelligence for biomedical research, including standards for secure and scalable data ecosystems.

Medical/Disease Research/Clinical Labs

- General education about biomedical research and support for scientific funding. Transparency of federal funding for medical research dollars, including indirect costs. Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments. - Federal funding for research and policy issues related to biomarkers and stress biology, including potential applications in defense and human performance. Fiscal Year 2027 National Defense Authorization Act (NDAA) and Fiscal Year 2027 Defense Appropriations. Federal policies and investments related to data infrastructure and artificial intelligence for biomedical research, including standards for secure and scalable data ecosystems.

Defense

- General education about biomedical research and support for scientific funding. Transparency of federal funding for medical research dollars, including indirect costs. Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments. - Federal funding for research and policy issues related to biomarkers and stress biology, including potential applications in defense and human performance. Fiscal Year 2027 National Defense Authorization Act (NDAA) and Fiscal Year 2027 Defense Appropriations. Federal policies and investments related to data infrastructure and artificial intelligence for biomedical research, including standards for secure and scalable data ecosystems.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem